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Introduction
Anaphylactic shock is sometimes life-threatening and accompanied by cardiac manifestations, which are clinically characterized by acute myocardial ischemia via coronary artery spasm and left ventricular (LV) dysfunction [1] [2] [3] [4] [5] [6] [7] [8] . Allergic activation of cardiac must cells is known to be of particular importance as a cause of the acute coronary syndrome, which is called "Kounis syndrome" [9] . Anaphylaxis-induced coronary vasoconstriction and cardiac dysfunction have also been demonstrated experimentally [10, 11] : in excised rat hearts, ovalbumin-induced anaphylaxis caused cardiac dysfunction characterized by the decreases in the systolic LV pressure (LVP) and the maximum incre-asing rate of LVP (dP/dt max ) along with coronary vasoconstriction. These findings strongly suggest that coronary vasoconstriction-induced myocardial ischemia and reduced LV contractility are involved in the pathogenesis of anaphylactic shock. Nevertheless, it is not known to what extent the reduced coronary blood flow (CBF) or the direct negative inotropic effect of chemical mediators is implicated in the detrimental action of anaphylaxis on cardiac contractility. There is no experimental study to examine the effect of CBF reduction on cardiac contractility as a mechanistic cause of anaphylactic cardiac dysfunction.
The aim of the present study was to determine the major mechanism of the anaphylactic LV dysfunction in isolated rat hearts by a maneuver of forcible CBF control, specifically whether it is primarily due to coronary vasoconstriction--induced CBF reduction. We hypothesized that if anaphylactic cardiac dysfunction is mainly due to the decrease in CBF, an imposed CBF reduction deteriorates LV contractility to the same extent as in anaphylaxis. Contractility of isolated coronary perfused rat hearts suffering from anaphylaxis was compared with that of CBF-reduced rat hearts. The LVP, pressures of the coronary artery (CAP) and vein (CVP), and CBF were directly and simultaneously measured before and after ovalbumin challenge in antigen-sensitized Wister rat hearts, as well as in non-sensitized rat hearts with imposed CBF reduction. The dP/dt max was determined during isovolumic contractions for the assessment of LV contractility without changes in preload. As a distinct feature of this study we applied the cross--circulated blood-perfusion method which permits analysis of LV mechanical works in excised whole heart preparations under more physiological conditions than crystalloid perfusion [12, 13] .
Methods

Animals
Male Wistar rats (n = 21) weighing 364 ± ± 17 g were assigned to one of the 3 groups: 1) the anaphylaxis group to be sensitized with ovalbumin for cardiac anaphylaxis experiment; 2) the flow reduction group not to be sensitized but to be used for the CBF reduction experiment; 3) the non-sensitized time control group. Rats were maintained at 23°C under pathogen-free conditions on a 12:12-h dark-light cycle, and allowed food and water ad libitum. The experiments were approved by the Animal Research Committee of Kanazawa Medical University.
Antigen sensitization
Rats in the anaphylaxis group, but not in the 2 other groups, were actively sensitized by the subcutaneous injection of an emulsion made by mixing equal volumes of complete Freund's adjuvant (0.5 mL) with 1 mg ovalbumin (grade V; Sigma Chemical Company, St. Louis, MO), as described previously [14] .
Isolated cross-circulated rat heart preparation
Two weeks after the sensitization, hearts were excised and coronary perfused with blood of metabolic supporter and blood supplier rats at a constant pressure by the cross-circulation method [13] . A thin latex balloon inserted into excised heart LV was connected to a pressure transducer (Life Kit DX-312, Nihon Kohden, Tokyo, Japan) to measure LVP during isometric contractions, with a maximum systolic LVP adjusted to 120-140 mm Hg. The heart rate was maintained at 300 bpm by electrical pacing to eliminate chronotropic influences. The systemic arterial pressure of a supporter rat served as the coronary perfusion pressure of 102 ± 14 (SD) mm Hg. Arterial pH, PO 2 , and PCO 2 of the supporter rat were maintained within their physiological ranges (pH = 7.3-7.4; PO 2 = 95--100 mm Hg; PCO 2 = 35-40 mm Hg) with supplemental oxygen and sodium bicarbonate.
Measurement items
LVP, CAP, and CVP were continuously measured with pressure transducers (Life Kit DX-312, Nihon Kohden) and digitally recorded by PowerLab (AD Instruments, Castle Hill, Australia), which could determine the time derivative of LVP and dP/dt max as an index of LV contractility in real time. Total CBF (mL/min/g) was continuously measured with an electromagnetic flow meter (MFV-3100, Nihon Kohden) placed in the middle of the coronary venous drainage tubing from the superior vena cava. For assessing coronary circulation, the coronary vascular resistance (CVR) was determined by the following equation:
Experimental protocol
Baseline measurements of LVP, CAP, CVP and CBF (with determinations of dP/dt max and CVR) were first performed before antigen injection. Following the baseline measurements, the antigen (ovalbumin 1.2 mg) dissolved in 300 μL saline was administered into the coronary artery, which yielded the forcible constriction of the left coronary Yuhichi Kuda et al., Cardiac contractility and coronary flow during anaphylaxis artery (main trunk) only in the sensitized hearts. Direct injection of the antigen ovalbumin into coronary arteries of isolated sensitized rat hearts is a well-established experimental method to create rat cardiac anaphylaxis models efficiently [10, 11] . The variables were continuously measured for 10 min after the antigen administration.
We determined the temporal changes in CBF and LV contractility during cardiac anaphylaxis, and LV contractility during imposed CBF reduction. For the flow reduction group, the coronary arterial catheter was constricted under monitoring the real-time CBF using a clamp so as to reproduce the temporal CBF changes in the same manner as observed in the anaphylaxis group.
Drugs
All drugs were purchased from Sigma Chemical Company (St. Louis, MO, USA). All drugs were dissolved in saline.
Statistical analysis
All results are expressed as the means ± SEM, unless stated otherwise. Multiple intra-group and between-group comparisons were performed using the repeated-measures analysis of variance, followed by the Bonferroni post hoc analysis. The p value of < 0.05 was considered statistically significant. All statistical analyses were performed by StatView (SAS Institute Inc., Cary, NC). Figure 1 shows the representative records of LVP, CAP, CVP, CBF, dP/dt max and CVR for 10 min after an antigen challenge from an anaphylaxis group rat heart (Fig. 1A) and flow reduction group rat heart (Fig. 1B) . Averaged values of the measured variables are shown at an interval of 30 s in Figures 2 and 3 . No significant differences in baseline values of the variables were observed between sensitized and non-sensitized hearts. The time control rat hearts showed no significant changes in the variables after antigen challenge.
Results
Anaphylaxis caused coronary vasoconstriction and parallel decreases in CBF and dP/dt max
During cardiac anaphylaxis evoked by the antigen, the CBF (4.4 ± 0.2 mL/min/g at the baseline) began to decrease as early as 1.5 min after antigen challenge, progressively decreased to the nadir of 1.8 ± 0.2 mL/min/g at 2.5 min, and then gradually returned toward the baseline level during 10 min measurements ( Fig. 2A) . CVP slightly but significantly decreased by ~2 mm Hg at 1.5-6.5 min, whereas CAP did not change throughout 10 min recordings (data not shown). The calculated CVR showed significant increases from the baseline 
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In parallel with the CBF reduction, the systolic LVP (132 ± 2 mm Hg at the baseline) and dP/dt max (3347 ± 163 mm Hg/s at the baseline) began to decrease at 1.5 min after antigen administration, decreased to the nadir of 60 ± 5 mm Hg and 1722 ± ± 115 mm Hg/s (i.e., to 46% and 51% of the baseline levels), respectively, at 3 min, and then gradually went back to the baseline level (Fig. 3) .
Imposed CBF reduction yielded the same degree of LV dysfunction as anaphylactic response
The flow reduction group rat hearts exhibited the decrease in CBF along with the increase in the Cardiology Journal 2014, Vol. 21, No. 1 CVR, which well mimicked the responses of the cardiac anaphylaxis group (Fig. 2) . The decrease in dP/dt max in response to imposed CBF reduction was very similar to that of the anaphylaxis group, not significantly different from the anaphylactic response (Fig. 3B) . Thus, the anaphylactic and forcible reductions in CBF caused coequal negative inotropic responses of LV contractility.
Discussion
In the current study, for the first time, we determined the role of reduced CBF in the LV dysfunction induced by cardiac anaphylaxis using isolated blood-perfused rat heart preparations. Distinct features of this study as compared with previous studies on cardiac anaphylaxis are 1) more physiological coronary perfusion with blood instead of crystalloid, and 2) the use of the flow reduction maneuver to determine the contribution of coronary vasoconstriction (reduced CBF) to LV dysfunction during cardiac anaphylaxis. There are two major findings: 1) after antigen administration to sensitized rat hearts, LV contractility (dP/dt max ) transiently decreased in parallel with CBF decrease via coronary vasoconstriction with complete recovery within 10 min; 2) the attenuation of LV contractility during the imposed CBF reduction to reproduce the anaphylactic CBF reduction was very similar to that in the anaphylactic response. These findings suggest that anaphylactic LV dysfunction is attributed primarily to reduced CBF due to coronary vasoconstriction and resulting myocardial ischemia.
Previous experimental and clinical studies suggested the involvements of coronary vasoconstriction, myocardial ischemia, and LV contractile failure in pathogenesis of anaphylactic hypotension [3-6, 8-11, 15] . However, it was not properly determined whether impaired CBF was primarily responsible for the detrimental effects of anaphylaxis on cardiac contractility, because of inappropriate conditions of the studies for assessment of cardiac functions (e.g., concomitant changes in uncontrolled preload and/or heart rates, non-physiological coronary perfusion with crystalloid). Using the flow control and blood perfusion methods, we clearly demonstrated the major role of coronary vasoconstriction and CBF reduction in anaphylactic LV dysfunction.
It is not clearly known to what extent the direct negative inotropic effect of chemical mediators such as histamine and leukotrienes is implicated in their detrimental action on cardiac contractility during anaphylaxis. The maximum reductions in LV contractility (dP/dt max ) were not significantly different between the anaphylaxis and CBF reduction groups, indicating that the direct negative inotropic effect of anaphylactic mediators, if any, would be relatively small. However, our results also suggest small positive inotropic action of chemical mediators during the recovery phase of reduced cardiac contractility: the restoration of LV contractility was more complete during anaphylaxis than in the forcible CBF reduction (Fig. 3B) , while the recovery of CBF was nearly identical (Fig. 2A) . The complete recovery during anaphylaxis may be due to the direct positive inotropic effect of chemical mediators and/or modulators including histamine (via the H 2 receptor) [16] , calcitonin gene-related peptide [17, 18] , and anaphylatoxins [19, 20] . Further studies are required on direct modifications of cardiac contractility by anaphylactic mediators and modulators.
As mentioned above, anaphylactic LV dysfunction was not persistent but only transient, with LV function completely recovering within 10 min along with CBF recovery, whereas the previous experimental studies using crystalloid perfusion reported incomplete recovery of LV contractility during cardiac anaphylaxis for longer periods (~60 min) of measurements [10, 11] . This inconsistency may be at least in part related to the difference in perfusate, i.e., blood vs. crystalloid: the use of more physiological perfusate of blood might enhance the release of chemical mediators or modulators to yield coronary vasodilation and/or positive inotropic effects. Thus, LV dysfunction may not strongly affect prolonged anaphylactic hypotension; in vivo, however, anaphylactic LV dysfunction may be protracted by mediators which are released systemically and reach the heart.
Conclusions
In summary, we determined the coronary vascular and LV contractility responses to anaphylaxis in isolated blood-perfused rat hearts, with special references to the relationship of CBF and LV contractility. LV contractility transiently decreased in parallel with CBF and the CBF control mimicking the temporal changes in CBF during anaphylaxis caused a reduction in LV contractility similar to that during anaphylaxis. These results suggest that LV dysfunction during anaphylaxis is attributed mainly to coronary vasoconstriction and resulting myocardial ischemia.
